Wilson disease: Current status and the future

Biochimie

Volumn 91, Issue 10, 2009, Pages 1278-1281

  Schilsky, Michael L ^a  

^a YALE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ATP7B; Ceruloplasmin; Copper; Treatment; Wilson disease

Indexed keywords

CHELATING AGENT; COPPER; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; WILSON DISEASE PROTEIN; ZINC DERIVATIVE;

AUTOSOMAL RECESSIVE DISORDER; BIOCHEMISTRY; CELL TRANSPLANTATION; CLINICAL ASSESSMENT; COPPER METABOLISM; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE COURSE; FEASIBILITY STUDY; GENE MUTATION; GENE THERAPY; GENETIC SCREENING; HUMAN; LABORATORY TEST; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MENTAL DISEASE; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TREATMENT INDICATION; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; CATION TRANSPORT PROTEINS; CHELATING AGENTS; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS;

ANIMALIA;

EID: 69749100311     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.07.012     Document Type: Short Survey

References (27)

1. Ala A., Walker A.P., Ashkan K., Dooley J.S., and Schilsky M.L. Wilson's disease. Lancet 369 (2007) 397-408
2. Ala A., Borjigin J., Rochwarger A., and Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41 (2005) 668-670
3. Ferenci P., Caca K., Loudianos G., Mieli-Vergani G., Tanner S., Sternlieb I., Schilsky M., Cox D., and Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 23 (2003) 139-142
4. Müller T., Koppikar S., Taylor R.M., Carragher F., Schlenck B., Heinz-Erian P., Kronenberg F., Ferenci P., Tanner S., Siebert U., Staudinger R., Mieli-Vergani G., and Dhawan A. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J. Hepatol. 47 (2007) 270-276
5. Xuan A., Bookman I., Cox D.W., and Heathcote J. Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis. J. Hepatol. 47 (2007) 428-433
6. Roberts E.A., and Schilsky M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology 47 (2008) 2089-2111
7. Davies L.P., Macintyre G., and Cox D.W. New mutations in the Wilson disease gene, ATP7B: implications for molecular testing. Genet. Test. 12 (2008) 139-145
8. Owada M., Suzuki K., Fukushi M., Yamauchi K., and Kitagawa T. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin. J. Pediatr. 140 (2002) 614-646
9. Nakayama K., Kubota M., Katoh Y., Sawada Y., Saito A., Nishimura K., Katsura E., Ichihara N., Suzuki T., Kouguchi H., Tamura M., Honma H., Kanzaki S., Itami H., Ohtake A., Kobayashi K., Ariga T., Fujieda K., Shimizu N., and Aoki T. Early and presymptomatic detection of Wilson's disease at the mandatory 3-year-old medical health care examination in Hokkaido Prefecture with the use of a novel automated urinary ceruloplasmin assay. Mol. Genet. Metab. 94 (2008) 363-367
10. Hahn S.H., Lee S.Y., Jang Y.J., Kim S.N., Shin H.C., Park S.Y., Han H.S., Yu E.S., Yoo H.W., Lee J.S., Chung C.S., Lee S.Y., and Lee D.H. Pilot study of mass screening for Wilson's disease in Korea. Mol. Genet. Metab. 76 (2002) 133-136
11. Kroll C.A., Ferber M.J., Dawson B.D., Jacobson R.M., Mensink K.A., Lorey F., Sherwin J., Cunningham G., Rinaldo P., Matern D., and Hahn S.H. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Mol. Genet. Metab. 89 (2006) 134-138
12. Brewer G.J., Askari F., Lorincz M.T., Carlson M., Schilsky M., Kluin K.J., Hedera P., Moretti P., Fink J.K., Tankanow R., Dick R.B., and Sitterly J. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch. Neurol. 63 (2006) 521-527
13. Korman J.D., Volenberg I., Balko J., Webster J., Schiodt F.V., Squires Jr. R.H., Fontana R.J., Lee W.M., Schilsky M.L., and Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 48 (2008) 1167-1174
14. Sen S., Felldin M., Steiner C., Larsson B., Gillett G.T., Olausson M., Williams R., and Jalan R. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transplant. 8 (2002) 962-967
15. Collins K.L., Roberts E.A., Adeli K., Bohn D., and Harvey E.A. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr. Nephrol. 23 (2008) 1013-1016
16. Medici V., Mirante V.G., Fassati L.R., Pompili M., Forti D., Del Gaudio M., Trevisan C.P., Cillo U., Sturniolo G.C., and Fagiuoli S. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transplant. 11 (2005) 1056-1063
17. Tamura S., Sugawara Y., Kishi Y., Akamatsu N., Kaneko J., and Makuuchi M. Living-related liver transplantation for Wilson's disease. Clin. Transplant. 19 (2005) 483-486
18. Groth C.G., Dubois R.S., Corman J., Gustafsson A., Iwatsuki S., Rodgerson D.O., Halgrimson C.G., and Starzl T.E. Metabolic effects of hepatic replacement in Wilson's disease. Transplant. Proc. 5 (1973) 829-833
19. Yoshida Y., Tokusashi Y., Lee G.H., and Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 111 (1996) 1654-1660
20. Irani A.N., Malhi H., Slehria S., Gorla G.R., Volenberg I., Schilsky M.L., and Gupta S. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol. Ther. 3 (2001) 302-309
21. Malhi H., Irani A.N., Volenberg I., Schilsky M.L., and Gupta S. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 122 (2002) 438-447
22. Park S.M., Vo K., Lallier M., Cloutier A.S., Brochu P., Alvarez F., and Martin S.R. Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease. Cell Transplant. 15 (2006) 13-22
23. Malhi H., Joseph B., Schilsky M.L., and Gupta S. Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease. Regen. Med. 3 (2008) 165-173
24. Meng Y., Miyoshi I., Hirabayashi M., Su M., Mototani Y., Okamura T., Terada K., Ueda M., Enomoto K., Sugiyama T., and Kasai N. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Biochim. Biophys. Acta 1690 (2004) 208-219
25. Ha-Hao D., Merle U., Hofmann C., Wesch H., Doll J., Auburger G., Tuma S., Strauss M., and Stremmel W. Chances and shortcomings of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats. Z. Gastroenterol. 40 (2002) 209-216
26. Merle U., Encke J., Tuma S., Volkmann M., Naldini L., and Stremmel W. Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. Scand. J. Gastroenterol. 41 (2006) 974-982
27. Merle U., Stremmel W., and Encke J. Perspectives for gene therapy of Wilson disease. Curr. Gene Ther. 7 (2007) 217-220